| CAS NO: | 1018927-63-3 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
EG00229 (EG-00229) is a novel and potent Neuropilin 1 (NRP1) receptor antagonist with anticancer activity. It acts by selectively inhibiting VEGF-A binding to NRP1 b1 domain with an IC50 of 3 μM, but has no effect on VEGFA binding to VEGFR-1 and VEGFR-2. EG00229 inhibits VEGFA binding to NRP1.
纯度：≥98%
CAS：1018927-63-3
m.cnreagent.com